Current projects

We encourage prospective D/P's (donor/participants) to become involved in current and future studies. If a study listed does not apply to your particular situation we still invite you to register so that we may include you in our database and contact you for future studies.

We are looking for D/P's in the following categories:

ID # Required D/P's Enrolled D/P's Remaining D/P's Inclusion Criteria
357239 1200 0 1200 Whole Blood, Serum and Plasma samples for HbA1C, Creatinine and BNP Testing in BCW-PR
357093 1 1 0 Pre-Selected HIV-2 Samples from Inventory
356924 9 8 1 Pre-Selected HBsAg Positive Serum Samples from Inventory
356769 139 123 16 Pre-Selected Anti-VZV Serum from Inventory for Pre-Testing
356627 250 17 233 Prospective Lesion Swab Collection TZC0120906/SACQ_0003497
356549 60 39 21 NP samples for testing on the Biofire RP2.1
356075 10 2 8 Whole Blood from Healthy Donors_TZC0122763/ SRF_0003506
355955 15 15 0 Pre-Selected RPR Negative Serum Samples from Inventory
355954 10 10 0 Pre-Selected RPR Positive Serum Samples from Inventory
355419 1500 0 1500 cobas® MPLX Respiratory for use on cobas® 5800/6800/8800 Systems: Reproducibility Study_ cX8-MPLX-584 _ RD006809
354831 500 0 500 Nasal Swab Collection from Symptomatic (Flu-Like) Subjects.
• Consented subjects only
• Symptomatic subjects only. Including at least two of the following:
- Fever
- Cough
- Malaise
- Sore throat
- Shortness of breath/difficulty breathing
- Rhinorrhea (runny or stuffy nose)
- Myalgia
- Headache
- New loss of taste or smell
- One or more GI symptoms (nausea, vomiting, diarrhea)
• Samples to be collected within 3d of Symptom onset
• Randomization plan based on subject collection order. Odd number subjects collect dry swab 1st. Even number subjects collect UVT swab 1st.
• There will be a 15 min wait time in between
study swab collection.
354779 30 24 6 Prospective Whole Blood Collection in Streck Tubes from HxV negative donors
60 & older
354307 80 80 0 Clinical Evaluation of the Xpert® Respiratory Panel for Adenovirus Detection, Cepheid 263C1-C3
353953 186 451 -265 Pre-Selected High Risk samples from Adult Donors
353947 186 41 145 Pre-Selected High risk samples from Pediatric Donors
353680 186 134 52 Pre-Selected HIV Negative Samples (Serum and Plasma) from Pregnant Females.
353341 5 5 0 HSV-2 IgG Double Testing on Elecsys at UM, and Bioplex at IRL
350630 10000 26 9974 Pre-selected Samples for Abbott (Generic JR)
349770 800 108 692 NP swab and Cough Record Collection for Evaluation Purposes
349651 1200 0 1200 Performance Evaluation of Elecsys EBV IgM, Elecsys EBV VCA IgG, Elecsys EBV EBNA IgG on the cobas e 411 Immunoassay Analyzer _ RD003522
349332 50 0 50 Venous Whole Blood and Capillary whole blood for Pre-Clinical Evaluation of the Xpert Hemorrhagic Fever Test_Protocol 259B2
349067 100 102 -2 Abnormal Urine samples from Donors with Pre-existing conditions for testing protocol in DxU 1800m urinalysis device (Protocol D04782).
349032 14000 0 14000 Comparator Method Testing Aptima and Alinity m
348573 100 100 0 Pre-Selected HxV NAT Negative K3EDTA Plasma samples from Inventory (Pooled Material)
345393 1000 961 39 Prospective Collection Symptomatic Donors

One or more flu-like symptoms such as: fever, cough, sore throat, runny or stuffy nose, muscle or body aches, headache, fatigue, vomiting, or diarrhea, with symptom onset within the past 7 calendar days
AND/OR

One or more COVID-19 symptoms such as: fever, dry cough, fatigue, loss of appetite, loss of smell or taste, body ache, or shortness of breath, with symptom onset within the past 7 calendar days
AND/OR

Subject has had a rapid positive COVID-19, flu A or flu B result in the past 48 hours, and symptom onset occurred within the past 4 calendar days, OR
Subject has had a rapid positive COVID-19, flu A, or flu B result in the past 48 hours and has not experienced symptom onset to date.
344846 300 71 229 Protocol: LIA-RESP-569 (RD006493)_Testing services for archived (frozen) samples received at BCW.
344240 60 7 53 Nasal Swab Collection from FluA/FluB Positive Donors
344221 15 0 15 Self Collected Vaginal Swabs and paired Cervical Swab (ThinPrep) from HPV Positive Donors
343643 104 104 0 HSV-2 IgG Triple Testing on LIAISON XL at BCW, Elecsys at UM and Bioplex at IRL
342645 1000 703 297 Protocol: cX8-MPLX-577 (RD006700)_Testing services for archived (frozen) samples received at BCW.
342354 60 10 50 Prospective Collection for Positive Flu A, Flu B, RSV or Covid Donors from BCW-PR
341447 30 20 10 Prospective Collection for Positive SARS-CoV-2 Donors
341446 30 1 29 Prospective Collection for Positive RSV Donors
341445 60 7 53 Prospective Collection for Positive Flu A and Flu B Donors
340981 400 960 -560 Protocol: cX8-MPLX-577 (RD006700)_Testing services for samples collected at external facilities.
340975 450 350 100 Protocol: LIA-RESP-569 Collection & Testing (RD006493) of Respiratory Swab Samples from Patients with Suspected Respiratory Tract Infections
340639 1000 424 576 Protocol: COL-RESP-528_Testeng services for samples collected at external facilities
340638 1000 582 418 Protocol: COL-RESP-528 - Collection of Respiratory Swab Samples from Patients with Suspected Respiratory Tract Infections - Miami
339042 159 2 157 HxV-VL Testing in Abbott m2000
336856 60 123 -63 Collection protocol for Panel construction (Custom HxV panels, Q_17332)
335726 100 5 95 SARS-CoV-2, Flu A, Flu B, and RSV Positive Nasal, Oropharyngeal, Nasopharyngeal and Blood Collection Protocol
334050 300 98 202 Female Vaginal Sample Collection Protocol for CT/GC Symptomatic donors
331596 115 46 69 Prospective collection from Healthy Donors
329522 4338 5307 -969 Disposition of BioRepository Samples -Urine and Plasma Negative samples from Talents
327905 50 17 33 Serum and Plasma samples from Pregnant donors with a high risk of HSV-2 Infection.
326193 20 3 17 Vaginal Swabs from Chlamydia Trachomatis Positive Donors
324678 32 2710 -2678 Samples selected from Siemens Biorepository to ship out to indicated locations.
319565 80 35 45 HIV, HCV, HBV and Syphilis cassette Testing using samples from our Inventory.
316965 100 26 74 HxV-VL Testing in Abbott m2000
293648 30 13 17 Prospective Collection for subjects with CoV-2, Flu A, Flu B, RSV
292590 10000 0 10000 A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Nasal Swab, Pharyngeal Swab, Vaginal Swab, Rectal Swab, Lesion Swab, Saliva Sample and/or Blood Samples from a positive or suspected positive D/Ps with Monkeypox
283190 200 113 87 Protocol No. LIA-STI-250 - cobas CT/NG/MG Nucleic acid test for use on the cobas Liat System: Feasibility Performance Evaluation
282610 10000 0 10000 A Multi Site, Longitudinal, Prospective Sample Collection Protocol in order to obtain Samples from Normal Healthy D/Ps
266931 120 17 103 PAS-19SUST053 Testing HBV VL (Abbott & Hologic)
251350 100 44 56 SARS-CoV-2 Positive Nasal, Oropharyngeal Dry Swab and Raw Saliva Collection Protocol
242206 5000 27709 -22709 COVID-19 Testing
239188 500 0 500 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella
227994 130 5 125 PAS-19SUST054 - HCV
225611 10000 0 10000 A Multi Site, Longitudinal, Prospective Collection Protocol in order to obtain Samples from Normal Healthy D/Ps
224514 600 76 524 Initiative to Screen Potential Study Candidates (SUST)
190737 5000 84 4916 SARS-CoV-2 Survey (PT)
182696 1000 355 645 Protocol: COL-RESP-528 - Collection of Respiratory Swab Samples from Patients with Suspected Respiratory Tract Infections
175121 1000 27 973 CBC Initiative
173768 10000 0 10000 A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Saliva, Sputum, Nasal, Pharyngeal, Blood and/or Finger Stick Specimens from SARS-CoV-2 positive subjects
152854 10000 0 10000 A Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from Normal Healthy D/Ps
151681 5000 3 4997 Refer to Processing Instructions @ Attachment Tab
149547 5000 355 4645 Refer to Processing Instructions @ Attachment Tab
TESTS TO SELECT PER LOCATION - REFER TO ATTACHMENT TAB
148791 5000 52 4948 Refer to Processing Instructions @ Attachment Tab
145574 5000 150 4850 Refer to Processing Instructions @ Attachment Tab
144620 5000 70 4930 Refer to Processing Instructions @ Attachment Tab
142755 5000 147 4853 Refer to Processing Instructions @ Attachment Tab
141914 1000 7 993 HIV Initiative
141493 5000 70 4930 HCV Viral Load and Genotype Survey (PT)
141491 5000 30 4970 HBV Viral Load Survey (PT)
141490 5000 75 4925 HIV Viral Load Survey (PT)
140923 5000 140 4860 Refer to Processing Instructions @ Attachment Tab
140922 5000 70 4930 Refer to Processing Instructions @ Attachment Tab
140530 5000 10 4990 Rubella IgG (AAB - PT)
140528 5000 6 4994 ToRCH (AAB - PT)
139409 5000 156 4844 Pregnancy (PT)
137933 5000 0 5000 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Cameroon
137683 930 235 695 Preeclampsia Blood Collection Protocol from Asymptomatic and Symptomatic Populations
129688 200 163 37 EBV / EBK Samples from National Center of Urology - Tbilisi, Georgia
129538 1000 309 691 RPR Initiative
128402 1000 73 927 CBC Initiative
124266 5000 143 4857 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Cote D'Ivoire
122931 5000 4091 909 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella
122654 5000 171 4829 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Swaziland
120851 140 26 114 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV
109382 100 32 68 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV
109381 300 6 294 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV
108692 1000 1259 -259 HxV Testing Initiative
102419 1000 511 489 Samples on hold for future shipments to China
98830 10000 0 10000 A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain PAP, Endocervical Swab, Vaginal Swab, Nasal Swab, Pharyngeal Swab, Rectal Swab, Urethral Swab and/or Urine Samples
98084 1000 576 424 CBC Qualifying Job Request
96278 195 185 10 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella
96055 40 2275 -2235 Hologic Panels for HIV and HCV
94841 500 1 499 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV - LGR
80997 5000 428 4572 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Cameroon
78138 300 140 160 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV
78137 300 414 -114 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV
74261 10000 0 10000 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella
68258 10000 0 10000 A Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from Normal Healthy D/Ps
63868 1000 1385 -385 Blinded HIV/HBV/HCV Prospective Blood Collection Protocol from Guinea Bissau
56717 20000 0 20000 A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain PAP , Endocervical, Vaginal, Nasal and/or Urine Samples
55075 10000 28 9972 Beta HCG Matched Set Prospective Blood Collection Protocol
54664 200 148 52 Random Cadaveric Samples
27615 15000 633 14367 Prospective Blood Collection Protocol in order to Collect Samples from Donor/Participants (D/Ps) in Low Socio-Economic Regions of the World
26761 10000 482 9518 HIV Positive Time Stability Whole Blood Collection Protocol
10694 3000 2234 766 HCV Longitudinal Prospective Blood Collection Protocol
10693 3000 369 2631 HBV Multi-Point Prospective Blood Collection Protocol
8568 300 1750 -1450 Positive Plasma Units from Blood Centers Around the World (HIV, HBsAg & HCV)



BCW helps clinicians during their research process through collection sites and D/P availability. Our collection sites have been duly inspected and adhere to our Good Manufacturing Practices thus ensuring reliability during the collection process. In addition to this we provide training seminars as part of our Quality Assurance in order to maintain the level of quality that our customers are accustomed to.

You will be invited to participate in research studies for the advancement of diagnostic technologies. Participation in these studies is voluntary. Our D/P's are informed of what the research projects are about and are given an Informed Consent, which evidences their willingness to participate. In order to protect our D/P's we never divulge your identity to the research facilities thus guaranteeing D/P confidentiality.



Contact us to learn more